About Entero Therapeutics

What does Entero Therapeutics do?

Entero Therapeutics is a provider of biopharmaceutical therapies for gastrointestinal diseases, including Latiglutenase, a recombinant digestive enzyme adjunct to a gluten-free diet for celiac disease; Adrulipase, a recombinant lipase to enable digestion of fats and nutrients in exocrine pancreatic insufficiency; and Capeserod, a selective 5-HT4 receptor partial agonist being developed for gastroparesis and other gastrointestinal indications.

Who are Entero Therapeutics's competitors?

Entero Therapeutics's competitors and similar companies include Oceana Therapeutics, Finch Therapeutics, Invendo Medical, SmartPill, and Quirem.

Where is Entero Therapeutics headquartered?

Entero Therapeutics is headquartered in United States.

How many employees does Entero Therapeutics have?

Entero Therapeutics has 1,000 employees 🔒.

When was Entero Therapeutics founded?

Entero Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Entero Therapeutics in?

Entero Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Entero Therapeutics

Who are the top strategic acquirers in Entero Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Entero Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Entero Therapeutics?

Top strategic M&A buyers groups and sectors for Entero Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Entero Therapeutics's sector and industry vertical

Which are the top PE firms investing in Entero Therapeutics's sector and industry vertical?

Top PE firms investing in Entero Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Entero Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Entero Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Entero Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Entero Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Entero Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Entero Therapeutics?

The key public trading comparables and valuation benchmarks for Entero Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Entero Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Entero Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Entero Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Entero Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Entero Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Entero Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.